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Abstract 
Background: Based on the results of a histological study of removed TG tissue 
NGAIT was found in 10,4% of the patients [1, 2]. At the same time, we observe processes of 
both thyroid epithelium metaplasia and lymphoid tissue hyperplasia that, undoubtedly, can be 
considered as an optional precancerous condition [3-8]. The option when cytomorphological 
and immunocytochemical examinations are carried out sequentially, using the same smear of 
a puncture material is optimal for PCE [9]. 
Methods: We have carried out an immunohistochemical study by means of 
monoclonal antibodies against Fas, FasL, Bcl-2, P53 and Ki67 antigens using the thyroid 
gland puncture material.   
Results: The results showed the degree of proliferative activity in the thyroid tissue in 
NGAIT. We found a high proliferative activity of lymphoid tissue, moderate proliferative 
activity of thyroid epithelial cells in the area of lymphoid infiltration and a low one – beyond 
the latter.  
Conclusions: The pronounced expression of Fas and FasL on the thyroid epithelial 
 476 
cells in the area of lymphoid infiltration indirectly indicates that NGAIT causes the processes 
of thyroid epithelial cells apoptosis due to the immunity. Increasing the number of 
immunoreactive cells expressing Ki67 in the area of lymphoid infiltration and destruction of 
thyroid epithelial cells, are indicative of follicular epithelial regeneration as a compensatory-
adaptive response of the organ. A pronounced Bsl-2 expression in lymphocytes prevents the 
cells from entering apoptosis and prolongs the cell survival time. There was a high expression 
of p53 protein in the nuclei of thyroid epithelial cells and follicular lamina, which can be 
explained by mutations in the gene p53, which allows the cells to find tolerance to apoptotic 
action of the immune system effectors. 
Abbreviations: NGAIT - nodular goiter combined with autoimmune thyroiditis, TG – 
thyroid gland, PCE – preoperative cytological examination. 
Key words: nodular goiter combined with autoimmune thyroiditis, fine needle 
biopsy, apoptosis, proliferation, thyroid gland. 
 
Introduction 
In modern literature there are many publications dealing with a study of nodular goiter 
combined with autoimmune thyroiditis (NGAIT) morphology [1 - 5]. However, some issues 
remain unresolved including that about the role of autoimmune thyroiditis (AIT) in the 
development of tumor processes. According to the literature, AIT leads to metaplasia 
processes in the thyroid epithelium, hyperplasia of lymphoid tissue, which undoubtedly can 
be considered as an optional precancerous condition [4 - 8]. 
The information that papillary cancer and lymphomas occur three times more 
frequently in patients with NGAIT confirms this idea [3, 5 - 8]. 
The total accuracy of clinical, instrumental and laboratory diagnostic methods for the 
establishment of morphological origin of nodular new growths in the TG even in the most 
daring conclusions does not exceed 80% [1 - 8]. This result cannot be satisfactory either for 
surgeons (unjustified over diagnosis of thyroid cancer) or for endocrinologists (inadequate 
and ill-timed selection of patients for surgical treatment) [10, 11]. 
Unfortunately, the chemical reagents used in the preparation of drugs for 
morphological studies by a standard method, block most of the antigenic determinants. That is 
why immunocytochemical and morphological studies of the biopsy material is performed on 
individual drugs, which leads to additional needle biopsies and prevents from the 
morphological identification of the cells reacting with antibodies. Instead, the best for PCE is 
the option when cytomorphological and immunocytochemical study is carried out consistently 
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on the same smear of a puncture material [12, 13]. 
One of the mechanisms of malignant transformation and progression is a cell cycle 
dysregulation with apoptosis inhibition and proliferation activation [14 - 20]. 
Membrane receptors Fas and Fas-L as well as Bcl-2 proteins are usually attributed to 
apoptosis regulation markers; and some researchers give the key role to Bcl-2 in the 
regulation of apoptosis [14 - 15]. Besides the proteins of bcl-2 class the suppressor gene p53 a 
nuclear phosphoprotein is also an apoptosis regulator [14, 17, 18]. This gene may occur in 
two types: p53 "wild" type, is believed to stimulate apoptosis, whereas mutant p53 has a 
similar effect on apoptosis, like Bcl-2 protein, which inhibits a programmed cell death. There 
are about 500 mutations of this gene [18]. Mutations of this protein in patients with 
malignant, benign and autoimmune thyroid diseases have not been studied sufficiently [11, 
18]. 
In addition to the factors of apoptosis, proliferation activity provides a very important 
information to determine the nature of precancerous condition and its prognosis in terms of 
malignancy. One of immunohistochemical markers of proliferation is the antigen Ki-67. It 
was shown that Ki-67 is on the cellular nuclei at all stages of the life cycle except G0 and G1 
early stages. After a cell leaves the mitotic cycle the antigen is not detected [14 - 17, 20]. The 
expression of these molecules can be detected by standard immunocytochemical methods that 
are simple enough to integrate into the process of fine needle aspiration biopsy (FNAB). 
Using additional diagnostic techniques such as immunohistochemistry, can assist in the 
interpretation of "uncertain" changes, but currently there are not any universally adopted 
standard molecular markers [10, 11, 13, 15]. 
It is quite necessary to solve these problems, because the correct choice of treatment 
strategy, timely surgical treatment and therefore the patient’s survival depend largely on the 
accuracy of PCE [11, 12]. 
That is why our aim was to study the processes of proliferation and apoptosis in 
thyroid puncture material under NGAIT using immunohistochemical method of investigation 
as well as determining the proliferative activity index.  
Material and methods 
We examined 75 women with nodular NGAIT during 2015-2016. The diagnosis was 
made clinically, by laboratory findings (thyroid peroxidase antibodies TPOA) - 60-250 U / ml 
thyroglobulin antibody (TGA) - 60-500 U / ml, thyroid-stimulating hormone (TSH) - 4.10 
mU / L) by ultrasound and it was confirmed histologically after the surgery. 
The study did not include patients with hyperthyroidism, manifest hypothyroidism, 
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arterial hypertension and cardiovascular disease, severe somatic pathology or after the 
menopause. 
All the patients were performed FNAB of the TG nodes controlled by ultrasound, 
while making at least three punctures of one node based on the fact that the percentage of 
inadequate punctates decreases depending on the number of punctures in the proportion when 
1 puncture is 16%, 2 punctures are 5 3%, 3 punctures are 4%, 4 punctures are 2.6% [10].  
While preparing the smears we used a method of restoration of antigen determinants 
activity developed and patented in the laboratory of the V. I. Komisarenko endocrinology 
Institute. It enables to combine cytomorphological and immunocytochemical researches in 
one cytological preparation and provides a possibility to compare morphological and 
immunocytochemical characteristics of certain cellular elements [9]. 
This method gives good results on the drugs that were kept after staining no more than 
three days. After this period, the results were unstable, which is due to the oxidization 
processes in some chemical compounds in the air [9,12,13]. To start an immunohistochemical 
reaction we used monoclonal antibodies to the following antigens: Mouse Human Ki-67 FITC 
Clone MIB-1; Anti-p53 Protein Monoclonal Antibody, FITC Conjugated, Clone DO-7; 
Mouse Anti-Human Apoptosis Regulator Bcl-2 (BCL2) Monoclonal, Unconjugated, Clone 
124 antibody; Mouse Anti-Human CD95 Monoclonal Antibody, Unconjugated, Clone 
FAS18; Mouse Anti-Human CD95L Monoclonal Antibody, Unconjugated, Clone NOK-1 by 
Dako Denmark A/S.(Denmark) 
The results of immunohistochemical reaction were evaluated by means of 
semiquantitative analysis, proposed by A.K. Khmelnytsky, according to the intensity of color 
"+ -" - small "+" - poor, "++" - moderate, "+++" - pronounced [13]. Assessment of 
immunoreactive cells was calculated by the formula (Fas, FasL, Bcl-2, P53) = N1 / N2 × 
100%, where N1 is the number of immuno-positive cells to Fas, FasL, Bcl-2, P53 receptors, 
N2 - the total number of the cellular nuclei per 1 square millimeter. Assessment of the IPA 
was calculated by the formula = NKi67 / N total × 100% where NKi67 is the total number of 
nuclei immune-positive to the protein Ki67, N total is the total number of nuclei per 1 mm2. 
Morphometric analysis was performed by means of the microscope Bresser BioScience Bino 
(Germany) with a digital camera Nikon DS-Fil, personal computer with installed software 
NIS-Elements F 3.2. 
Results and discussion 
The immunohistochemical study found that in all 75 cases (100%) the expression of 
Ki67 in thyroid epithelial cells was weak "+" and moderate "++" by nature, which manifested 
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itself in the form of brown or light brown staining of nuclei in the thyroid epithelial cells. The 
number of immunoreactive cells in the preparation was distributed unevenly. In the thyroid 
epithelial cells, near the areas of thyroid epithelium destruction, near lymphoid infiltration 
there was an increased expression of Ki67, IPA varied from 9.75 to 11.37% (median was 
10.56%). In calculating the number of immunoreactive thyroid epithelial cells which were 
beyond the lymphoid infiltration, proliferation index reduced from 2.5 to 3.7% (median 
3.15%). The lymphoid tissue was characterized by a brown color and a high percentage of 
immunoreactive cells - from 93 to 95% (median 94%) (Fig. 1, A). 
We have also found a significant number of thyroid epithelial cells expressing Fas. 
The cytoplasmic membrane of thyroid epithelial cells was characterized by a brown «++» and 
deep brown «+++» coloring. The number of immunoreactive cells ranged from 47 to 63% 
(median 55%). It should be noted that a significant expression "+++" was observed in the 
areas with a pronounced lymphoid infiltration. FasL expression was higher "+++" in follicles 
and adjacent areas of lymphoid infiltration "++" which averaged 46.10% in the cell ratio (Fig. 
1, B, C). Co-expression of Fas and FasL in the areas of lymphoid follicles infiltration around 
thyroid epithelial cells indicates that Fas and FasL are not directly involved in apoptosis of 
thyroid epithelial cells but induce this process through the development of proapoptotic 
cytokines. 
Bcl-2 was slightly «-» expressed by the thyroid epithelium unlike the lymphoid tissue, 
whose cytoplasm became brown «+++». When the lymphoid follicles were formed without 
clear boundaries, the lymphoid tissue of the thyroid gland was evenly colored in the center 
and the periphery of follicles. When mature follicles were formed, there was no coloring in 
the center but the mantle zone of lymphoid follicles was intensely colored. (Fig. 1, D). The 
lymphoid tissue beyond the nodules was being intensively expressed by bsl-2 in the area of 
thyroid follicles and in the stroma of the gland. When analyzing the number of cells 
expressing bsl-2 we found from 87 to 93% of immunoreactive cells (median 90%).  
There was a high expression of protein р53 in the nuclei of thyroid epithelial cells and 
in the follicular lamina, at the same time there was a prominent positive reaction with the 
nuclei colored deep brown. (fig.1, Е). Staining with this marker was local by nature, and there 
were no more than 7-9 nuclei in one field of view. The concentration of immunoreactive cells 
was from 64 to 71% (median 65, 5 %). An increased density of p53-positive cells can be 
explained by mutations in the gene p53, which allows the cells to find tolerance to apoptotic 
action of the immune system effectors [14, 15, 18]. 
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Conclusions  
1. A pronounced expression of Fas and FasL on the thyroid epithelial cells, in the 
areas of lymphoid infiltration is indicative of the fact that in case of NGAIT immunologically 
caused processes of the thyroid epithelial cells apoptosis occur.  
2. Co-expression of Fas and FasL in the areas of the lymphoid infiltration around 
the thyroid epithelial cells indicates that Fas and FasL are not directly involved in apoptosis of 
the thyroid epithelial cells, but they induce this process by producing proapoptotic cytokines.    
3. Increasing the number of immunoreactive cells expressing Ki67 in the area of 
the lymphoid infiltration and destruction of the thyroid epithelial cells is indicative of the 
follicular epithelium regeneration as a compensatory-adaptive response of the organ.   
4. A pronounced expression of bsl-2 in the lymphocytes prevents the cells from 
entering apoptosis as well as prolonging their survival time, which, undoubtedly, plays an 
important role in morphogenesis of the lymphoid tissue tumor diseases аnd prolonged 
processes of apoptosis and regeneration of the thyroid epithelium can also contribute to 
cancerogenesis. 
5. An increased density of р53-positive cells can be explained by mutations of 
р53 gene, which allows the cells to find tolerance to an apoptotic action of the immune 
 481 
system effectors. 
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